Clinical Trial Update: Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

View source ↗

Summary

A clinical trial update describing a study to quantify systemic immunosuppression to personalize cancer therapy and that the trial is currently recruiting acros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Small Cell Lung Cancer
• Squamous Cell Carcinoma of Head and Neck
• Urinary Bladder Cancer

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Melanoma, Breast Cancer | Status: RECRUITING